Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Fresenius Kabi Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (286)
Cancellation by sponsor (126)
Prescription medicine registration (12)
Australian Public Assessment Report (AusPAR) (6)
Prescription medicine decision summary (2)

Date

2024 (46)
2023 (45)
2022 (29)
2021 (13)
2020 (31)
2019 (59)
2018 (17)
2017 (14)
2016 (18)
2015 (23)
2014 (8)
2013 (26)
2012 (18)
2011 (5)
2010 (5)
2009 (1)
2008 (13)
2007 (13)
2006 (26)
2002 (2)
2001 (3)
1994 (7)
1992 (3)
1991 (7)

Results for "[search-keyword]"

Search

Sponsor content

432 result(s) found, displaying 171 to 180

Fresenius Kabi Australia Pty Ltd - Medical device electrical cable, general purpose (310143)

8 October 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Fresenius Kabi Australia Pty Ltd - Medical device electrical cable, general purpose.
Fresenius Kabi Australia Pty Ltd - Enteral feeding pole (308931)

3 September 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Fresenius Kabi Australia Pty Ltd - Enteral feeding pole.
INTRALIPID 10% 50g/500mL injection bottle Cancelled under Section 30(1)(c) of the Act

30 June 2020

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
Idacio

25 June 2020

Prescription medicine decision summary

Australian prescription medicine decision summary
IDACIO (Fresenius Kabi Australia Pty Ltd)

15 June 2020

Prescription medicine registration

Active ingredients: adalimumab.
PHOSPHOPREP Lemon Flavour Powder for solution sachet Cancelled under Section 41GL(d) of the Act

12 June 2020

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
GO KIT Cancelled under Section 41GL(d) of the Act

12 June 2020

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
GO KIT PLUS Cancelled under Section 41GL(d) of the Act

12 June 2020

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
PHOSPHOPREP Rasberry Flavour Powder for solution sachet Cancelled under Section 41GL(d) of the Act

12 June 2020

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
INTRALIPID 30% 250mL injection bottle Cancelled under Section 30(1)(c) of the Act

12 June 2020

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd

Pages

First page
Previous page
…
Page 14
Page 15
Page 16
Page 17
Current page 18
Page 19
Page 20
Page 21
Page 22
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.